News

Eclinso’s trialforce Platform and XClinical’s Electronic Data Capture (EDC) system, Marvin, offer unparalleled flexibility and adaptability to both Sponsors and Clinical Research Organizations (CROs) for capturing and managing

The comparator-controlled study, conducted in Australia under its contract with the US Department of Health and Human Services’ Office of Biomedical Advanced Research and Development Authority, will enroll

The gluten free supplement is available in three delicious flavors chocolate, vanilla and cookies & creme. The company claims that each serving of the product contains 27gm of

Ublituximab is a third generation chimeric monoclonal antibody targeting an epitope on the CD20 antigen found on B lymphocytes. TG has announced the closing of a capital raise,

The terms of the manufacturing agreement have not been disclosed. Velesco operates a 10,000ft2 cGMP manufacturing facility in Kalamazoo, Michigan. Rubicon has signed a clinical supply agreement with

Developed in collaboration with Genentech, BI-204 is a monoclonal antibody targeting oxidised forms of low-density lipoprotein cholesterol. In the randomized placebo controlled double-blind multicenter Phase IIa study, BI-204

Nexafed has also demonstrated the ability to block the extraction of the pseudoephedrine from the tablets, which is the first step in the two other common methods of

The funding support received will be used by the company to support global late Phase 2 clinical trials in refractory epilepsy. YKP3089 was discovered initially to have a

VEPACEL is a pre-pandemic influenza vaccine indicated for active immunization in adults 18 years and older against the H5N1 subtype of influenza A, commonly known as bird or